BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2002
View Archived Issues
Ilex sublicenses CD52 diagnostic rights to Ventana
Read More
Novel alphav integrin antagonists and their use in osteoporosis
Read More
Vanilloid VR1 antagonists identified at GSK
Read More
Merck & Co. synthesizes new alpha2/alpha3-selective GABA-A agonist
Read More
Gruenenthal presents novel opioid agents for diarrhea, IBS, pain and immunomodulation
Read More
Tetracyclic MCH receptor modulators identified by Tularik scientists
Read More
Phase I testing of ACP-HIP cleared to begin by Health Canada
Read More
Two series of azole-based antifungal agents prepared and tested at Aventis
Read More
New caspase activators in Cytovia development pipeline
Read More
RenaZorb begins testing in animals
Read More
Thuris to evaluate CNCDS's compounds in antiaging and Alzheimer's models
Read More
European approval for room-temperature storage of Betaferon
Read More
Vectura and GSK sign dry powder drug formulation agreement
Read More
AMD-3100 shows potential in myocardial infarction and for CD34+ cell mobilization/collection
Read More
Apomine as a new therapeutic approach to multiple myeloma
Read More
NanoCarrier and Kirin collaborate on anticancer therapeutics
Read More
Phase I testing of Abiogen's OGP drug to begin in Italy
Read More
CTCE-0021 rapidly mobilizes PMNs and hematopoietic progenitor cells
Read More
Nastech's intranasal morphine product shows rapid absorption and good pain relief
Read More
Pharmacokinetic studies in monkeys suggest feasibility of s.c. administration of PRO-38747
Read More
Exherin cleared to enter phase I trials in Canada
Read More
NeoTherapeutics renamed Spectrum Pharmaceuticals
Read More
CTA filed in Europe for MDX-018 in autoimmune indication
Read More
Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML
Read More
Treatment begins in phase II trial of myoblast cell transplantation
Read More